News & Updates
Meet with Christopher Kata, Director of Sales & Marketing on November 13th at the OBIO Event “Talking to Doctors & Patients: Using Primary Market Research Data to Seal the Deal with Investors”! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: November 13th 11:00 am – 2:00 pm Where: 100 College St Suite 150…
Read More
Meet with Christopher Kata, Director of Sales & Marketing on November 9th at the SoCalBio Digital Health Conference! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: November 9th 8:00 am – 6:30 pm Where: Hotel Maya 700 Queensway Dr, Long Beach, CA 90802 Registration: https://socalbio.org/socalbio-digital-health-confernce/ SoCalBio Digital Health Conference The…
Read More
Meet with Christopher Kata, Director of Sales & Marketing on November 7th at the Bio In The Capital – CLSA networking event in Sacramento! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: November 7th 5:30 pm – 7:00 pm Where: Urban Roots Brewery & Smokehouse 1322 V St Sacramento, CA 95818 Registration: https://califesciences.org/bio-in-the-capital/ …
Read More
Meet with Christopher Kata, Director of Sales & Marketing on October 29th and 30th at the Life Sciences Future event in Philadelphia! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: October 29th – 30th 7:00 am – 6:00 pm Where: Pennsylvania Convention Center – Philadelphia, PA Registration: https://lnkd.in/eJJKVaG Welcome…
Read More
The FDA has announced it is taking additioanl steps to improve the security of Medical Devices. The agency will soon release a new draft of premarket guidance document with recommendations to combat growing security threats. “In addition, the agency announced multiple partnerships with manufacturers, hospitals and more — as well as the release of a…
Read More
MassDevice has written an excellent article outlining the benefits Medical Device Trials receive when using a Unified eClinical Suite. “Implementing a unified data platform for medical device trials can yield significant improvements in efficiency, transparency, and standardization, providing resource- and budget-strapped trial teams with accessible, more accurate data for faster, more informed decisions.” Read The…
Read More
James P. Allison of MD Anderson Cancer Center in Houston and Tasuku Honjo of Kyoto University in Japan have won the Nobel Prize in physiology or medicine for advances in harnessing the immune system to fight cancer. Read The Entire Article Here.
Read More
TrialStat Launches Updated TrialStat EDC at SCDM, Introducing New Features to Further Simplify Your Data Management and Study Collaboration Needs – Meet with us at Booth #312 As the volume of per-trial data grows, compliance requirements increase, and Sponsors are more responsible than ever for trial oversight, TrialStat has responded by releasing the next generation…
Read More
“Researchers have now identified three new molecular drug targets in Naegleria fowleri and a number of drugs that are able to inhibit the amoeba’s growth in a laboratory dish. Several of these drugs are already approved by the US Food and Drug Administration for other uses, such as antifungal agents, the breast cancer drug tamoxifen…
Read More
“What happens to skin cells when they are confronted with blood? A team of researchers from Oslo University Hospital, led by Emma Lång and Stig Ove Bøe, performed experiments on blood-deprived cells that were subsequently exposed to blood serum. Remarkably, all the cells started to move and grow in the same direction as soon as…
Read More